As a valued reader of our Future of Biopharma blog, we invite and encourage you to subscribe to receive exclusive VIP discount offers, notification of private industry events, and access to proprietary content and pre-press industry biosimialrs news. We assure you that our sophisticated segmentation strategies guarantee you receive only those notifications that are relevant to you. Now in its 13th year, the Business of Biosimilars & Generic Drugs is the world's largest development and commercialization event for the follow-on biopharmaceutical industry, bringing drug development and market access executives the tools to compete and maximize pipeline profitability in today's global competitive environment.
Plus, after years of waiting, the FDA has released its long awaited user fee structure and draft guidelines for the development and regulatory approval of biosimilars in the US. This event will help you focus on the most significant new points in these guidelines and further accelerate what indeed promises to be a significantly abbreviated path to approval for your follow-on biologics. Business of Biosimilars and Generic Drugs will take place September 10-12, 2012, in Boston, MA.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment